GI symptoms (n=34) | Non-GI symptoms (n=210) | P value | |
Age (months) | |||
Median (IQR) | 14 (3–93) | 86 (28–139) | 0.01* |
Age group distribution (n (%)) | 0.02* | ||
0–1 month | 2 (5.9) | 9 (4.3) | |
1 month-12 months | 14 (41.2) | 30 (14.3) | |
1–3 years old | 4 (11.8) | 23 (11.0) | |
3–6 years old | 3 (8.8) | 24 (11.4) | |
6–10 years old | 5 (14.7) | 61 (29.1) | |
10–18 years old | 6 (17.6) | 63 (30.0) | |
Sex (male) (n (%)) | 19 (55.9) | 131 (62.4) | 0.47 |
Birth weight (kg) | 3.3 (2.9–3.7) | 3.3 (3.0–3.6) | 0.90 |
Clinical diagnostic classification (n (%)) | 0.47 | ||
Asymptomatic | 0 (0) | 51 (24.3) | <0.01* |
Acute upper respiratory infection | 7 (20.6) | 43 (20.4) | |
Mild pneumonia | 25 (73.5) | 107 (51.0) | |
Severe pneumonia | 0 (0) | 7 (3.3) | |
Critical pneumonia | 2 (5.9) | 2 (1.0) | |
Contact history with infected family member | 28 (79.4) | 180 (85.7) | 0.62 |
Symptoms (n (%)) | |||
Fever | 24 (70.6) | 75 (35.7) | <0.01* |
Vomit | 23 (67.7) | – | |
Diarrhoea | 15 (44.1) | – | |
Abdominal pain | 4 (11.8) | – | |
Decreased feeding | 8 (23.5) | – | |
Stool SARS-CoV-2 RT-PCR results (105 patients tested) (n (%)) | |||
Positive | 7/17 (41.2) | 32/88 (36.4) | 0.70 |
*denotes statistical significance.
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.